Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LPGO.ST
- Price
- 0.12
- Stock movement up
- +0.01 (4.64%)
- Company name
- Lipigon Pharmaceuticals AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 18.39M
- Ent value
- 10.22M
- Price/Sales
- 2.05
- Price/Book
- 1.00
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -14.33%
- 1 year return
- -59.21%
- 3 year return
- -69.38%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
LPGO.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.05 |
| Price to Book | 1.00 |
| EV to Sales | 1.14 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 148.33M |
| EPS (TTM) | -0.14 |
| FCF per share (TTM) | -0.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 8.97M |
| Gross profit (TTM) | 1.38M |
| Operating income (TTM) | -21.92M |
| Net income (TTM) | -22.11M |
| EPS (TTM) | -0.14 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 15.38% |
| Operating margin (TTM) | -244.34% |
| Profit margin (TTM) | -246.48% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 10.74M |
| Net receivables | 0.00 |
| Total current assets | 20.76M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 21.03M |
| Accounts payable | 869.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.56M |
| Total liabilities | 2.56M |
| Shareholder's equity | 18.47M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -32.33M |
| Capital expenditures (TTM) | 235.00K |
| Free cash flow (TTM) | -32.56M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -119.70% |
| Return on Assets | -105.14% |
| Return on Invested Capital | -119.70% |
| Cash Return on Invested Capital | -176.28% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.13 |
| Daily high | 0.14 |
| Daily low | 0.12 |
| Daily Volume | 637K |
| All-time high | 10.15 |
| 1y analyst estimate | 1.60 |
| Beta | 0.58 |
| EPS (TTM) | -0.14 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LPGO.ST | S&P500 | |
| Current price drop from All-time high | -98.78% | -12.89% |
| Highest price drop | -99.01% | -56.47% |
| Date of highest drop | 4 Mar 2025 | 9 Mar 2009 |
| Avg drop from high | -74.71% | -11.07% |
| Avg time to new high | 260 days | 12 days |
| Max time to new high | 1036 days | 1805 days |
COMPANY DETAILS
Marketcap
18.39M
Marketcap category
Small-cap
Description
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.
Employees
6
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found